Cargando…
What do we know about the antibody responses to SARS-CoV-2?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide causing a pandemic with millions of infected people and deaths. Currently, the scientific community is working hard to develop a specific vaccine or treatment. However, since antibody production is an important part of...
Autores principales: | Lagunas-Rangel, Francisco Alejandro, Chávez-Valencia, Venice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826124/ https://www.ncbi.nlm.nih.gov/pubmed/33524881 http://dx.doi.org/10.1016/j.imbio.2021.152054 |
Ejemplares similares
-
What do we know about the function of SARS-CoV-2 proteins?
por: Justo Arevalo, Santiago, et al.
Publicado: (2023) -
What do we know about the SARS-CoV-2 coronavirus in the environment?
por: Núñez-Delgado, Avelino
Publicado: (2020) -
What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021) -
Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2
por: Kloc, Malgorzata, et al.
Publicado: (2022) -
Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2021)